14/02/2006
Completion of the acquisition of Sciencom Limited
ReGen Therapeutics Plc (‘ReGen’), is pleased to announce that all of the conditions to the acquisition of the entire issued share capital of Sciencom Limited (the ‘Acquisition’) have now been satisfied and that the Acquisition was completed earlier today.
Admission of 1,562,500 new ordinary shares of ReGen to trading on the AIM market of the London Stock Exchange, issued as consideration for the Acquisition also took place earlier today.
For further information, please contact:
Andrew Marshall
Greycoat Communications
Tel: 020 7960 6007
Mobile: 07785 297111